Other Liabilities, Noncurrent in USD of WINDTREE THERAPEUTICS INC /DE/ from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly Other Liabilities, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Other Liabilities, Noncurrent for the quarter ending 30 Sep 2025 was $3.8M, unchanged year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $3.8M $0 0% 30 Sep 2025 10-Q 19 Nov 2025
Q2 2025 $3.8M $0 0% 30 Jun 2025 10-Q 19 Aug 2025
Q1 2025 $3.8M $0 0% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $3.8M $0 0% 31 Dec 2024 10-Q 19 Nov 2025
Q3 2024 $3.8M $0 0% 30 Sep 2024 10-Q 26 Nov 2024
Q2 2024 $3.8M $0 0% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 $3.8M $0 0% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $3.8M $0 0% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $3.8M $0 0% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $3.8M $0 0% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $3.8M $0 0% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $3.8M $0 0% 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 $3.8M +$200K +5.56% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $3.8M +$600K +18.8% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $3.8M +$1M +35.7% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $3.8M +$1M +35.7% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $3.6M +$1.2M +50% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $3.2M +$2.2M +220% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $2.8M 31 Mar 2021 10-Q 13 May 2021
Q4 2020 $2.8M 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $2.4M +$2.29M +2164% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 $1M +$906K +964% 30 Jun 2020 10-Q 14 Aug 2020
Q3 2019 $106K -$60K -36.1% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $94K -$88K -48.4% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $63K -$30K -32.3% 31 Mar 2019 10-Q 20 May 2019
Q4 2018 $175K +$75K +75% 31 Dec 2018 10-K 03 Apr 2020
Q3 2018 $166K +$49K +41.9% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $182K +$58K +46.8% 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 $93K -$38K -29% 31 Mar 2018 10-Q 21 May 2018
Q4 2017 $100K -$38K -27.5% 31 Dec 2017 10-K/A 23 Apr 2019
Q3 2017 $117K -$38K -24.5% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 $124K -$38K -23.5% 30 Jun 2017 10-Q 21 Aug 2017
Q1 2017 $131K +$91K +228% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $138K +$95K +221% 31 Dec 2016 10-K 17 Apr 2018
Q3 2016 $155K +$99K +177% 30 Sep 2016 10-Q 14 Nov 2016
Q2 2016 $162K +$103K +175% 30 Jun 2016 10-Q 10 Aug 2016
Q1 2016 $40K -$156K -79.6% 31 Mar 2016 10-Q 12 May 2016
Q4 2015 $43K -$126K -74.6% 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 $56K -$86K -60.6% 30 Sep 2015 10-Q 05 Nov 2015
Q2 2015 $59K -$55K -48.2% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 $196K -$518K -72.5% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $169K -$369K -68.6% 31 Dec 2014 10-K 29 Mar 2016
Q3 2014 $142K -$289K -67.1% 30 Sep 2014 10-Q 07 Nov 2014
Q2 2014 $114K -$319K -73.7% 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 $714K +$233K +48.4% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $538K +$95K +21.4% 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $431K -$239K -35.7% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $433K -$253K -36.9% 30 Jun 2013 10-Q 08 Aug 2013
Q1 2013 $481K -$222K -31.6% 31 Mar 2013 10-Q 07 May 2013
Q4 2012 $443K -$246K -35.7% 31 Dec 2012 10-K 17 Mar 2014
Q3 2012 $670K -$21K -3.04% 30 Sep 2012 10-Q 14 Nov 2012
Q2 2012 $686K -$22K -3.11% 30 Jun 2012 10-Q 14 Aug 2012
Q1 2012 $703K 31 Mar 2012 10-Q 15 May 2012
Q4 2011 $689K +$55K +8.68% 31 Dec 2011 10-K 15 Mar 2013
Q3 2011 $691K 30 Sep 2011 10-Q 14 Nov 2011
Q2 2011 $708K 30 Jun 2011 10-Q 15 Aug 2011
Q4 2010 $634K 31 Dec 2010 10-K 30 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.